APO RESEARCH · REPORT
Biological Indicators
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Product & engineering
Understand the product.
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
Selected research
Industry Growth & Trends
Global Biological Indicators Industry Growth and Trends Forecast to 2032
Market perspective
Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.
According to APO Research, the global Biological Indicators market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
Read the full market overview
This report provides a structured, data-driven view of the global Biological Indicators market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Biological Indicators market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biological Indicators market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biological Indicators.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Biological Indicators market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Biological Indicators Market by Company
3M
Getinge Group
Cantel Medical
Mesa Laboratories
Steris
Fuze Medical
Matachana
Hu-Friedy
Advanced Sterilization
Bag Health Care
Terragene
Andersen
GKE
Biological Indicators Segment by Type
Self-Contained Biological Indicator
Biological Indicator Strip
Biological Indicators Segment by Application
Hospital
Pharma Companies
Others
Biological Indicators Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Biological Indicators companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Self-Contained Biological Indicator
- Biological Indicator Strip
Applications
- Hospital
- Pharma Companies
- Others
Companies covered
- 3M
- Getinge Group
- Cantel Medical
- Mesa Laboratories
- Steris
- Fuze Medical
- Matachana
- Hu-Friedy
- Advanced Sterilization
- Bag Health Care
- Terragene
- Andersen
- GKE
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Biological Indicators Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Biological Indicators Market Size by Region (2021-2032)
- 1.4.1 Global Biological Indicators Market Size by Region (2021-2026)
- 1.4.2 Global Biological Indicators Market Size by Region (2027-2032)
- 1.5 Key Regions Biological Indicators Market Size (2021-2032)
- 1.5.1 North America Biological Indicators Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Biological Indicators Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Biological Indicators Market Size Growth Rate (2021-2032)
- 1.5.4 South America Biological Indicators Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Biological Indicators Market Size Growth Rate (2021-2032)
2 Biological Indicators Market by Type
- 2.1 Type Introduction
- 2.1.1 Self-Contained Biological Indicator
- 2.1.2 Biological Indicator Strip
- 2.2 Global Biological Indicators Market Size by Type
- 2.2.1 Global Biological Indicators Market Size Overview by Type (2021-2032)
- 2.2.2 Global Biological Indicators Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Biological Indicators Market Size Forecasted by Type (2027-2032)
- 2.3 Global Biological Indicators Market Size by Regions
- 2.3.1 North America Biological Indicators Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Biological Indicators Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Biological Indicators Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Biological Indicators Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Biological Indicators Market Size Breakdown by Type (2021-2026)
3 Biological Indicators Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Pharma Companies
- 3.1.3 Others
- 3.2 Global Biological Indicators Market Size by Application
- 3.2.1 Global Biological Indicators Market Size Overview by Application (2021-2032)
- 3.2.2 Global Biological Indicators Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Biological Indicators Market Size Forecasted by Application (2027-2032)
- 3.3 Global Biological Indicators Market Size by Regions
- 3.3.1 North America Biological Indicators Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Biological Indicators Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Biological Indicators Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Biological Indicators Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Biological Indicators Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Biological Indicators Industry Trends
- 4.2 Biological Indicators Industry Drivers
- 4.3 Biological Indicators Industry Opportunities and Challenges
- 4.4 Biological Indicators Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Biological Indicators Revenue (2021-2026)
- 5.2 Global Biological Indicators Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Biological Indicators Key Company Headquarters & Area Served
- 5.4 Global Biological Indicators Company, Product Type & Application
- 5.5 Global Biological Indicators Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Biological Indicators Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Biological Indicators Players Market Share by Revenue in 2025
- 5.6.3 2025 Biological Indicators Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 3M
- 6.1.1 3M Company Information
- 6.1.2 3M Business Overview
- 6.1.3 3M Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 3M Biological Indicators Product Portfolio
- 6.1.5 3M Recent Developments
- 6.2 Getinge Group
- 6.2.1 Getinge Group Company Information
- 6.2.2 Getinge Group Business Overview
- 6.2.3 Getinge Group Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Getinge Group Biological Indicators Product Portfolio
- 6.2.5 Getinge Group Recent Developments
- 6.3 Cantel Medical
- 6.3.1 Cantel Medical Company Information
- 6.3.2 Cantel Medical Business Overview
- 6.3.3 Cantel Medical Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cantel Medical Biological Indicators Product Portfolio
- 6.3.5 Cantel Medical Recent Developments
- 6.4 Mesa Laboratories
- 6.4.1 Mesa Laboratories Company Information
- 6.4.2 Mesa Laboratories Business Overview
- 6.4.3 Mesa Laboratories Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Mesa Laboratories Biological Indicators Product Portfolio
- 6.4.5 Mesa Laboratories Recent Developments
- 6.5 Steris
- 6.5.1 Steris Company Information
- 6.5.2 Steris Business Overview
- 6.5.3 Steris Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Steris Biological Indicators Product Portfolio
- 6.5.5 Steris Recent Developments
- 6.6 Fuze Medical
- 6.6.1 Fuze Medical Company Information
- 6.6.2 Fuze Medical Business Overview
- 6.6.3 Fuze Medical Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Fuze Medical Biological Indicators Product Portfolio
- 6.6.5 Fuze Medical Recent Developments
- 6.7 Matachana
- 6.7.1 Matachana Company Information
- 6.7.2 Matachana Business Overview
- 6.7.3 Matachana Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Matachana Biological Indicators Product Portfolio
- 6.7.5 Matachana Recent Developments
- 6.8 Hu-Friedy
- 6.8.1 Hu-Friedy Company Information
- 6.8.2 Hu-Friedy Business Overview
- 6.8.3 Hu-Friedy Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Hu-Friedy Biological Indicators Product Portfolio
- 6.8.5 Hu-Friedy Recent Developments
- 6.9 Advanced Sterilization
- 6.9.1 Advanced Sterilization Company Information
- 6.9.2 Advanced Sterilization Business Overview
- 6.9.3 Advanced Sterilization Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Advanced Sterilization Biological Indicators Product Portfolio
- 6.9.5 Advanced Sterilization Recent Developments
- 6.10 Bag Health Care
- 6.10.1 Bag Health Care Company Information
- 6.10.2 Bag Health Care Business Overview
- 6.10.3 Bag Health Care Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Bag Health Care Biological Indicators Product Portfolio
- 6.10.5 Bag Health Care Recent Developments
- 6.11 Terragene
- 6.11.1 Terragene Company Information
- 6.11.2 Terragene Business Overview
- 6.11.3 Terragene Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Terragene Biological Indicators Product Portfolio
- 6.11.5 Terragene Recent Developments
- 6.12 Andersen
- 6.12.1 Andersen Company Information
- 6.12.2 Andersen Business Overview
- 6.12.3 Andersen Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Andersen Biological Indicators Product Portfolio
- 6.12.5 Andersen Recent Developments
- 6.13 GKE
- 6.13.1 GKE Company Information
- 6.13.2 GKE Business Overview
- 6.13.3 GKE Biological Indicators Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 GKE Biological Indicators Product Portfolio
- 6.13.5 GKE Recent Developments
7 North America
- 7.1 North America Biological Indicators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Biological Indicators Market Size by Country (2021-2026)
- 7.3 North America Biological Indicators Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Biological Indicators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Biological Indicators Market Size by Country (2021-2026)
- 8.3 Europe Biological Indicators Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Biological Indicators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Biological Indicators Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Biological Indicators Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Biological Indicators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Biological Indicators Market Size by Country (2021-2026)
- 10.3 South America Biological Indicators Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Biological Indicators Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Biological Indicators Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Biological Indicators Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst